This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
An overview of how weight decay factors into index performance and the practical implications for index-following strategies.
28,655 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
When rates trend downward, cash-flow investors face a tougher math as prices rise and competition heats up. This guid...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
A convincing fake bank call sent a Virginia resident on a cash handoff, revealing how scammers use authority and urge...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
Patience and a long time horizon are the most powerful tools in any investor’s kit. This guide explains why waiting f...
RLJ Lodging Trust has fallen about 8% over the last 12 months. Yet a sizeable stake by a key investor suggests there ...
A once-hot cybersecurity stock has fallen 40%, yet a large investor just increased exposure. This guide breaks down w...
Investors watched spacemobile stock crushed thursday move sharply as AT&T, Verizon, and T-Mobile signaled a bold sate...
As Warren Buffett steps back, Greg Abel’s potential move to buy a stock Buffett loves has investors buzzing. This art...